Stock Ratings | With the stock potentially up 123.33%, Maxim Group raised its price target on Unisys (UIS) stock to $9 and upgraded its rating to "Buy."

Unisys Corporation
Enovix Corporation
Sohu.com Limited Sponsored ADR
Red Violet, Inc.
COMPASS Pathways Plc Sponsored ADR

Unisys Corporation

UIS

0.00

Enovix Corporation

ENVX

0.00

Sohu.com Limited Sponsored ADR

SOHU

0.00

Red Violet, Inc.

RDVT

0.00

COMPASS Pathways Plc Sponsored ADR

CMPS

0.00

Major US investment bank ratings are used to track the latest valuations and target prices on Wall Street daily, and to explore potential stock investment opportunities.

Hazard Warning:

Investing in small-cap stocks can be risky. Be prepared for potential liquidity challenges, high volatility, limited information, and financial instability. Always diversify your investments.

Today's Key Ratings and Concerns

Maxim Group: Unisys Corporation Unisys Corporation(UIS.US) upgraded to "Buy", with a $9 price target.

Canaccord Genuity: Maintained a “Buy” rating on Enovix Corporation - Common Stock(ENVX.US) ), raising the price target from $20 to $22.

Citigroup: Maintains a “Buy” rating on Sohu.com, Inc.(SOHU.US) ), raising the price target from $17 to $20.

Lake Street: Initial rating for Red Violet, Inc.(RDVT.US) ) with a "Buy" recommendation and a $60 price target.

HC Wainwright & Co.: Maintained a "Buy" rating on Compass Pathways ( COMPASS Pathways plc(CMPS.US) ), while lowering the price target to $40 from $45.

The symbol Classification Target price Current price Potential increase/decrease rate (Classification) Agency
Unisys Corporation(UIS.US) to lift $9.0 $4.03 123.33% Maxim Group
Enovix Corporation - Common Stock(ENVX.US) to lift $22.0 $10.99 100.18% Canaccord Genuity
Sohu.com, Inc.(SOHU.US) to lift $20.0 $14.43 38.6% Citigroup
Tower Semiconductor Ltd(TSEM.US) to lift $66.0 $50.98 29.46% Benchmark
BuildABear Workshop, Inc.(BBW.US) to lift $64.0 $50.92 25.69% DA Davidson
Red Violet, Inc.(RDVT.US) Initial classification $60.0 $45.07 33.13% Lake Street
COMPASS Pathways plc(CMPS.US) cut $40.0 $4.6 769.57% HC Wainwright & Co.
NeoGenomics, Inc.(NEO.US) cut $11.0 $5.67 94.0% Piper Sandler
ARTELO BIOSCIENCES INC(ARTL.US) cut $18.0 $9.93 81.27% D. Boral Capital
Newell Brands Inc(NWL.US) cut $9.0 $4.975 80.9% Canaccord Genuity

comments:
Target price unit and current price: US dollar;
Current Price: As of the latest closing price of US stocks;
Potential increase/decrease ratio = (Agency target price - current price) / current price 100% (Current price = last closing price up to the time of census)

Lifting

Stifel: Maintained a "Buy" rating on Advanced Energy Industries, Inc.(AEIS.US) ), raising the price target from $130 to $150.

Keefe, Bruyette & Woods: Maintained Atlantic Union ATLANTIC UNION BANKSHARES CORP(AUB.US) ) "Market Match" rating, raising price target from $33 to $34.

DA Davidson: Maintains a "Buy" rating on Build-A-Bear Workshop ( BuildABear Workshop, Inc.(BBW.US) ), raising the price target from $60 to $64.

Piper Sandler: Maintained an "Overweight" rating on Cboe Global Markets ( CBOE Holdings, Inc.(CBOE.US) ), raising the price target from $250 to $265.

Keefe, Bruyette & Woods: Maintains Cboe Global Markets ( CBOE Holdings, Inc.(CBOE.US) ) "Market Match" rating, raising price target from $243 to $248.

DA Davidson: Maintains a “Neutral” rating on Cognex Corporation(CGNX.US) ), raising the price target from $32 to $35.

Jefferies: Maintains a "Buy" rating on Datadog(DDOG.US) ), raising the price target from $135 to $160.

Keefe, Bruyette & Woods: Maintained an “Outperform” rating for Eagle Financial Services Eagle Financial Services, Inc.(EFSI.US) ), raising the price target from $38 to $39.

Wells Fargo: Maintained Everest Group Everest Group, Ltd. Common Stock(EG.US) rating at "Market-Weight," raising the price target from $362 to $371.

Canaccord Genuity: Maintained a “Buy” rating on Enovix Corporation - Common Stock(ENVX.US) ), raising the price target from $20 to $22.

Loop Capital: Maintained a "Hold" rating on Fortune Brands Innovations(FBIN.US) ), raising the price target from $53 to $61.

Citigroup: Maintains a "Buy" rating on GFL Environmental Holdings Inc.(GFL.US) ), raising the price target from $56 to $58.

First coverage

Lake Street: Initial rating for Red Violet, Inc.(RDVT.US) ) with a "Buy" recommendation and a $60 price target.

reduction

D. Boral Capital: Maintains a "Buy" rating on Artelo Biosciences ( ARTELO BIOSCIENCES INC(ARTL.US) ), lowering the price target from $20 to $18.

Barclays: Maintained an “Overweight” rating on Baxter International Inc.(BAX.US) ), lowering the price target from $41 to $36.

Stifel: Baxter Baxter International Inc.(BAX.US) ) downgraded to "Hold" with a price target cut from $36 to $25.

DA Davidson: Maintained a "Neutral" rating on Builders Builders FirstSource, Inc.(BLDR.US) ), lowering the price target from $135 to $125.

Jefferies: Maintains a "Buy" rating on Bruker Corporation(BRKR.US) ), lowers the price target from $70 to $60.

Citigroup: Maintains a "Neutral" rating on Bruker Corporation(BRKR.US) ), lowering the price target from $40 to $38.

Barclays: Maintained Bruker Corporation(BRKR.US) rating at "Overweight", lowered price target to $43 from $46.

DA Davidson: Maintains a "Neutral" rating on BlueLinx Holdings Inc.(BXC.US) ), lowering the price target from $80 to $75.

Citigroup: Maintains a "Neutral" rating on Confluent, Inc.(CFLT.US) ), lowering the price target from $30 to $20.

Editor's Note: This content was generated by Sahm's AI-powered SaaS tool and reviewed by our editorial team.
Risk Warning: Investing involves risks, and securities prices may rise, fall, or even become worthless. Investing does not guarantee profits and may result in losses. Past performance does not necessarily reflect future performance. Before making any investment decision, investors should evaluate their financial situation, investment objectives, experience, and risk tolerance, and understand the nature of the investment products and the risks associated with them. For further details on the nature and risks of each investment product, please read the relevant offering documents carefully. If you have any questions, you are advised to seek independent professional advice.